Tara Abbondanza
Nurse Practitioner · Arcadia, CANPI 1730355173
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 193 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,126 and has fallen 57.4% since, to $480 in 2025. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$939
- Pfizer$640
- Boehringer Ingelheim$367
- Johnson & Johnson$345
- Astellas Pharma US Inc$331
- Amgen$176
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,79095%
- Education$1905%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 58 | $939 |
| Pfizer | 30 | $640 |
| Boehringer Ingelheim | 16 | $367 |
| Johnson & Johnson | 14 | $345 |
| Astellas Pharma US Inc | 11 | $331 |
| Amgen | 11 | $176 |
| Boston Scientific | 6 | $155 |
| Lexicon Pharmaceuticals, Inc. | 5 | $128 |
| Bayer | 6 | $122 |
| E.r. Squibb & Sons, L.L.C. | 4 | $96 |
| Alnylam Pharmaceuticals Inc. | 3 | $91 |
| AstraZeneca | 4 | $74 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $68 |
| Inspire Medical Systems, Inc. | 3 | $54 |
| Actelion Pharmaceuticals US, Inc. | 3 | $52 |
| Abiomed | 1 | $44 |
| Sobi, Inc | 2 | $43 |
| Merck | 2 | $36 |
| Lilly USA, LLC | 1 | $35 |
| Heartflow, Inc. | 2 | $33 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $27 |
| Amarin Pharma, Inc. | 1 | $23 |
| Altathera Pharmaceuticals LLC | 1 | $22 |
| Convatec Inc. | 1 | $22 |
| Novo Nordisk | 1 | $21 |
| Abbott | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
How this compares
$3,980 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $103 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Arcadia
- Lynsey LakinArcadia$540K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.